Carmen Wolf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Carmen Wolf has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Patrick Langguth
University Hospital Schleswig-Holstein
4 shared publications - Olav Jansen
Universitätsklinikum Schleswig-Holstein
3 shared publications - Naomi Larsen
Department of Radiology and Neuroradiology, University Hospital Schleswig-Holstein, Kiel, Germany
2 shared publications - Schekeb Aludin
Clinic for Radiology and Neuroradiology, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.
2 shared publications Agreen Horr
Radiology and Neuroradiology, University Hospital Schleswig-Holstein – Campus Kiel, Kiel, Germany
1 shared publication- Agreen Horr
Department of Radiology and Neuroradiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
1 shared publication
Latest Publications
- Open Access
- 21 February 2026
- Published by MDPI AG in Neurology International
- Vol. 18 (2) , 38
Experimental Characterisation of Differently Composed Thrombus Entities with Spectral-Detector-CT
Background/Objectives: Thrombus composition influences the success of endovascular therapy in stroke, but conventional CT is limited in determining it. Spectral-detector-CT (SDCT) can apply material-decomposition and virtual monoenergetic (MonoE) imaging, which may provide a way to gain information on thrombus composition. This experimental study aimed to evaluate the differentiability of heterogeneous thrombi with variable red blood cell (RBC) content using SDCT. Methods: Ten thrombus entities with different compositions on RBC and plasma, thus fibrin content, were manufactured (volumetric RBC%/Plasma% = 90/10; 80/20; 70/30; 60/40; 50/50; 40/60; 30/70; 20/80; 10/90; 5/95) and scanned in an SDCT. Conventional Hounsfield-unit (HU) values, spectral electron density (ED), effective atomic number (Z-effective) and HU in MonoE maps ranging from 40– to 200 keV were evaluated for thrombus differentiation. Results: Conventional HU increased with RBC content, allowing us to differentiate the entities (p < 0.001). ED values also increased with RBC content and allowed for differentiation too (p < 0.001). Z-effective values showed no differences among the different entities (p > 0.05). Regarding the mass-attenuation curves from 40 to 200 keV the different thrombi showed a similar curve progression with highest HU values at 40 and lowest at 200 keV. The thrombi could be distinguished overall at each monoenergetic level by HU (p < 0.001 for each level). The absolute decrease in HU between 40 and 200 keV was thereby not significantly different between the different entities, but the relative decrease was, as it was more pronounced in thrombi with lower RBC content (p < 0.001). Conclusions: Spectral CT enables differentiation between thrombi with different RBC and fibrin contents by means of ED or analysis of the mass-attenuation curve. This offers alternative possibilities that go beyond characterisation based on CT-density alone. The additional inclusion of spectral parameters in thrombus diagnostics could therefore improve diagnosis and treatment.
- 21 February 2026
- Published by MDPI AG in Neurology International
- Vol. 18 (2) , 38
Open AccessExperimental Characterisation of Differently Composed Thrombus Entities with Spectral-Detector-CT
Background/Objectives: Thrombus composition influences the success of endovascular therapy in stroke, but conventional CT is limited in determining it. Spectral-detector-CT (SDCT) can apply material-decomposition and virtual monoenergetic (MonoE) imaging, which may provide a way to gain information on thrombus composition. This experimental study aimed to evaluate the differentiability of heterogeneous thrombi with variable red blood cell (RBC) content using SDCT. Methods: Ten thrombus entities with different compositions on RBC and plasma, thus fibrin content, were manufactured (volumetric RBC%/Plasma% = 90/10; 80/20; 70/30; 60/40; 50/50; 40/60; 30/70; 20/80; 10/90; 5/95) and scanned in an SDCT. Conventional Hounsfield-unit (HU) values, spectral electron density (ED), effective atomic number (Z-effective) and HU in MonoE maps ranging from 40– to 200 keV were evaluated for thrombus differentiation. Results: Conventional HU increased with RBC content, allowing us to differentiate the entities (p < 0.001). ED values also increased with RBC content and allowed for differentiation too (p < 0.001). Z-effective values showed no differences among the different entities (p > 0.05). Regarding the mass-attenuation curves from 40 to 200 keV the different thrombi showed a similar curve progression with highest HU values at 40 and lowest at 200 keV. The thrombi could be distinguished overall at each monoenergetic level by HU (p < 0.001 for each level). The absolute decrease in HU between 40 and 200 keV was thereby not significantly different between the different entities, but the relative decrease was, as it was more pronounced in thrombi with lower RBC content (p < 0.001). Conclusions: Spectral CT enables differentiation between thrombi with different RBC and fibrin contents by means of ED or analysis of the mass-attenuation curve. This offers alternative possibilities that go beyond characterisation based on CT-density alone. The additional inclusion of spectral parameters in thrombus diagnostics could therefore improve diagnosis and treatment.
- Open Access
- 7 February 2025
- Published by MDPI AG in Neurology International
- Vol. 17 (2) , 25
Cardiac CT in Large Vessel Occlusion Stroke for the Evaluation of Non-Thrombotic and Non-Atrial-Fibrillation-Related Embolic Causes
Background: The purpose of this study is the evaluation of imaging findings of acute-phase cardiac CT (cCT) in stroke patients with large vessel occlusion (LVO) to identify potential cardioembolic sources (CES) in patients without intracardiac thrombi and atrial fibrillation (AF). Material and Methods: This retrospective study included 315 patients with LVO who underwent cCT imaging in the acute stroke setting. The images were analysed for 15 imaging findings following the established minor and major cardioembolic risk factors. The final stroke aetiology was determined using the TOAST classification through interdisciplinary consensus following a thorough clinical evaluation. Multivariate regression analysis was performed to identify imaging findings associated with CES. Results: A cardioembolic aetiology was identified on cardiac CT in 211 cases (70%). After adjustment for AF and intracardiac thrombi, the multivariate regression analysis revealed significant associations with left ventricular dilation (adjusted odds-ratio (AOR) 32.4; 95% CI 3.0–349; p = 0.004), visible interatrial right-to-left shunt (AOR 30.8; 95% CI 2.7–341.3; p = 0.006), valve implants (AOR 24.5; 95% CI 2.2–270.9; p = 0.009), aortic arch atheroma grade > II (AOR 6.9; 95% CI 1.5–32.8; p = 0.015) and post-ischaemic myocardial scars (AOR 6.3, 95% CI 1.2–34.1; p = 0.032) as independent risk factors for a cardioembolic aetiology. The combined model achieved an area under the ROC curve of 0.83. Conclusions: In patients with LVO without AF and intracardiac thrombi as a cause, the presence of left ventricular dilatation, interatrial right-to-left shunts, valve implants, post-ischaemic myocardial scarring and advanced aortic arch atheroma (grade > 2) in particular is significantly associated with a cardioembolic cause of stroke and should be add-on evaluated in acute-phase cCT. Further investigations are warranted to confirm these associations.
- 7 February 2025
- Published by MDPI AG in Neurology International
- Vol. 17 (2) , 25
Open AccessCardiac CT in Large Vessel Occlusion Stroke for the Evaluation of Non-Thrombotic and Non-Atrial-Fibrillation-Related Embolic Causes
Background: The purpose of this study is the evaluation of imaging findings of acute-phase cardiac CT (cCT) in stroke patients with large vessel occlusion (LVO) to identify potential cardioembolic sources (CES) in patients without intracardiac thrombi and atrial fibrillation (AF). Material and Methods: This retrospective study included 315 patients with LVO who underwent cCT imaging in the acute stroke setting. The images were analysed for 15 imaging findings following the established minor and major cardioembolic risk factors. The final stroke aetiology was determined using the TOAST classification through interdisciplinary consensus following a thorough clinical evaluation. Multivariate regression analysis was performed to identify imaging findings associated with CES. Results: A cardioembolic aetiology was identified on cardiac CT in 211 cases (70%). After adjustment for AF and intracardiac thrombi, the multivariate regression analysis revealed significant associations with left ventricular dilation (adjusted odds-ratio (AOR) 32.4; 95% CI 3.0–349; p = 0.004), visible interatrial right-to-left shunt (AOR 30.8; 95% CI 2.7–341.3; p = 0.006), valve implants (AOR 24.5; 95% CI 2.2–270.9; p = 0.009), aortic arch atheroma grade > II (AOR 6.9; 95% CI 1.5–32.8; p = 0.015) and post-ischaemic myocardial scars (AOR 6.3, 95% CI 1.2–34.1; p = 0.032) as independent risk factors for a cardioembolic aetiology. The combined model achieved an area under the ROC curve of 0.83. Conclusions: In patients with LVO without AF and intracardiac thrombi as a cause, the presence of left ventricular dilatation, interatrial right-to-left shunts, valve implants, post-ischaemic myocardial scarring and advanced aortic arch atheroma (grade > 2) in particular is significantly associated with a cardioembolic cause of stroke and should be add-on evaluated in acute-phase cCT. Further investigations are warranted to confirm these associations.
- 22 October 2024
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 197 (06) , 690-692
Persistierende linke obere Hohlvene mit Einmündung in den linken Vorhof: Fehlende Kontrastierung der Pulmonalarterien in der CT-Angiographie bei einem Patienten mit fulminanter Lungenarterienembolie
Die persistierende linke obere Hohlvene (LSVC, engl. left superior vena cava) ist eine seltene Gefäßvariante, die häufig asymptomatisch ist und daher als Zufallsbefund entdeckt wird (Ratliff et al. Int J Cardiol. 2006; 113(2): 242–246). Je nach Anatomie der LSVC können Symptome und Risiken auftreten. Wenn die LSVC in den linken Vorhof mündet, entsteht ein Rechts-Links-Shunt, der das Risiko für Hypoxämie und paradoxe Thrombembolien erhöht. Wir stellen einen Patienten mit dem Zufallsbefund einer LSVC mit Einmündung in den linken Vorhof vor, der im Rahmen der Diagnostik einer Lungenarterienembolie auffiel. Received: 07 March 2024 Accepted after revision: 06 September 2024 Article published online: 22 October 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 22 October 2024
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 197 (06) , 690-692
Persistierende linke obere Hohlvene mit Einmündung in den linken Vorhof: Fehlende Kontrastierung der Pulmonalarterien in der CT-Angiographie bei einem Patienten mit fulminanter Lungenarterienembolie
Die persistierende linke obere Hohlvene (LSVC, engl. left superior vena cava) ist eine seltene Gefäßvariante, die häufig asymptomatisch ist und daher als Zufallsbefund entdeckt wird (Ratliff et al. Int J Cardiol. 2006; 113(2): 242–246). Je nach Anatomie der LSVC können Symptome und Risiken auftreten. Wenn die LSVC in den linken Vorhof mündet, entsteht ein Rechts-Links-Shunt, der das Risiko für Hypoxämie und paradoxe Thrombembolien erhöht. Wir stellen einen Patienten mit dem Zufallsbefund einer LSVC mit Einmündung in den linken Vorhof vor, der im Rahmen der Diagnostik einer Lungenarterienembolie auffiel. Received: 07 March 2024 Accepted after revision: 06 September 2024 Article published online: 22 October 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 10 July 2023
- Published by Springer Nature in Applied Psychophysiology and Biofeedback
- Vol. 48 (4) , 403
Correction to: Clinical Value of Using Heart Rate Variability Biofeedback Before Elective CT Coronary Angiography to Reduce Heart Rate and the Need for BetaBlockers
- 10 July 2023
- Published by Springer Nature in Applied Psychophysiology and Biofeedback
- Vol. 48 (4) , 403
Open AccessCorrection to: Clinical Value of Using Heart Rate Variability Biofeedback Before Elective CT Coronary Angiography to Reduce Heart Rate and the Need for BetaBlockers